Unichem Laboratories to consolidate its US formulation business under one entity. The board will meet on September 30th to consider the integration of Bayshore Pharmaceuticals LLC into Unichem Pharmaceuticals Inc.
New Delhi, Sep 23 (PTI) Drug firm Unichem Laboratories on Monday said its board will meet next week to consider consolidation of its US formulation business under one entity.
The board, on September 30, will consider integration and consolidation of the generics formulations business in the US market of Bayshore Pharmaceuticals LLC into Unichem Pharmaceuticals Inc, it said in a regulatory filing.
The initiative is to consolidate all the Ipca Group's US generics formulations business under one entity, it added.
Shares of Unichem Laboratories were trading 2.59 per cent down at Rs 628.05 apiece on the BSE.
Home » Market News » Unichem to Consolidate US Formulation Business | Latest News
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback